Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.8209
-0.1084 (-11.66%)
At close: Jun 27, 2025, 4:00 PM
0.8260
+0.0051 (0.62%)
After-hours: Jun 27, 2025, 7:54 PM EDT

Lexicon Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
31.2131.081.20.140.324
Upgrade
Revenue Growth (YoY)
1251.21%2481.48%766.19%-53.36%-98.76%-92.55%
Upgrade
Cost of Revenue
83.988458.9752.5255.05153.05
Upgrade
Gross Profit
-52.76-52.92-57.77-52.38-54.75-129.06
Upgrade
Selling, General & Admin
111.45131.9112.5448.0832.3444.23
Upgrade
Operating Expenses
112.4131.9112.5448.0832.3444.23
Upgrade
Operating Income
-165.16-184.82-170.31-100.46-87.09-173.29
Upgrade
Interest Expense
-12.47-15.58-13.1-2.78-0.8-14.54
Upgrade
Interest & Investment Income
12.6312.297.731.60.132.77
Upgrade
EBT Excluding Unusual Items
-165-188.1-175.68-101.64-87.76-185.06
Upgrade
Merger & Restructuring Charges
------5.5
Upgrade
Gain (Loss) on Sale of Assets
-----132.59
Upgrade
Asset Writedown
------1.6
Upgrade
Other Unusual Items
-12.3-12.3-1.44-0.3-1
Upgrade
Pretax Income
-177.3-200.4-177.12-101.94-87.76-58.57
Upgrade
Net Income
-177.3-200.4-177.12-101.94-87.76-58.57
Upgrade
Net Income to Common
-177.3-200.4-177.12-101.94-87.76-58.57
Upgrade
Shares Outstanding (Basic)
349320221166146111
Upgrade
Shares Outstanding (Diluted)
349320221166146111
Upgrade
Shares Change (YoY)
48.45%44.73%33.42%13.79%31.41%-5.06%
Upgrade
EPS (Basic)
-0.51-0.63-0.80-0.62-0.60-0.53
Upgrade
EPS (Diluted)
-0.51-0.63-0.80-0.62-0.60-0.53
Upgrade
Free Cash Flow
-168.46-179.81-162.37-90.18-88.24-143.06
Upgrade
Free Cash Flow Per Share
-0.48-0.56-0.73-0.54-0.61-1.29
Upgrade
Gross Margin
-169.04%-170.25%----
Upgrade
Operating Margin
-529.15%-594.63%-14145.35%-72273.38%-29224.83%-722.17%
Upgrade
Profit Margin
-568.04%-644.78%-14710.88%-73341.01%-29448.99%-244.11%
Upgrade
Free Cash Flow Margin
-539.71%-578.52%-13485.63%-64875.54%-29610.07%-596.19%
Upgrade
EBITDA
-164.6-184.28-169.76-100.03-86.8-170.35
Upgrade
D&A For EBITDA
0.570.530.550.430.292.93
Upgrade
EBIT
-165.16-184.82-170.31-100.46-87.09-173.29
Upgrade
Revenue as Reported
31.2131.081.20.140.324
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q